“Clinical Experience With Intravenous and Oral Formulations of the Novel Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Heavily Pretreated Patients With Hematological Malignancies”. 2009. Hematology Meeting Reports (formerly Haematologica Reports) 1 (8). https://doi.org/10.4081/hmr.v1i8.297.